美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

減肥藥

1,248.89

+19.721.60%

漲家數：6

跌家數：1

平家數：- -

市盈率：- -

高：1,251.72

開：1,229.96

低：1,229.96

收：1,229.17

資料載入中...

輝瑞又雙叒叕放棄一款口服 GLP-1，肥胖管線僅剩 1 款藥物

Insight数据库

輝瑞4月14日成交額為13.66億美元

諾和諾德4月14日成交額為5.33億美元

輝瑞的GLP失敗了

生物药大时代

安進4月14日成交額為7.28億美元

金十數據整理：每日美股市場要聞速遞（4月14日，週一）

輝瑞終止每日服用減肥藥物研發後股價下跌

环球市场播报

輝瑞(PFE.US)“減肥藥雄心”破碎：患者肝損傷導致Danuglipron開發終止

輝瑞(PFE.N)抹去盤前跌幅，現漲1.2%。

因輝瑞放棄肥胖藥物，諾和諾德(NVO.N)盤前上漲4.7%。

輝瑞(PFE.N)盤前股價下跌3.2%。

瑞士山德士公司在美國對安進公司提起反壟斷訴訟

禮來(LLY.US)公佈減肥藥Zepbound三年臨牀數據持續用藥可維持95%減重效果

Altimmune, Inc.盤中異動下午盤股價大漲5.05%報4.37美元

碩迪生物盤中異動急速拉昇5.12%

諾和諾德盤中異動股價大漲4.21%報63.79美元

輝瑞4月10日成交額為15.75億美元

諾和諾德4月10日成交額為6.10億美元

禮來4月10日成交額為29.99億美元

安進4月10日成交額為13.08億美元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK4599/news?page=4"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"減肥藥","latestPrice":1248.89,"timestamp":1745351999999,"preClose":1229.1708,"halted":0,"volume":59333994,"delay":0,"changeRate":0.016043,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盤","change":19.719238,"latestTime":"04-22 16:00:00 EDT","open":1229.9553,"high":1251.7179,"low":1229.9553,"amount":4734433013.28595,"amplitude":0.017705,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1745366400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":9.990998,"peRate":34.826857,"turnoverRate":0.005617,"increases":6,"decrements":1,"flats":0,"marketCap":1332454704192,"floatMarketCap":1254704086112},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1251.7179,"amplitude":0.017705,"preClose":1229.1708,"low":1229.9553,"pbRate":"9.990998","latestPrice":1248.89,"volume":59333994,"delay":0,"open":1229.9553,"prevYearClose":1305.0607,"prevWeekClose":1251.235,"prevMonthClose":1314.3724,"prevQuarterClose":1314.3724,"fiveDayClose":1208.2393,"twentyDayClose":1377.3098,"sixtyDayClose":1328.9048,"secType":"PLATE","market":"US","turnoverRate":0.005617,"peRate":34.826857,"marketCap":1332454704192,"floatMarketCap":1254704086112,"timestamp":1745351999999,"nameCN":"減肥藥"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":6,"down":1,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2527341315","title":"輝瑞又雙叒叕放棄一款口服 GLP-1，肥胖管線僅剩 1 款藥物","url":"https://stock-news.laohu8.com/highlight/detail?id=2527341315","media":"Insight数据库","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527341315?lang=zh_tw&edition=fundamental","pubTime":"2025-04-15 11:45","pubTimestamp":1744688751,"startTime":"0","endTime":"0","summary":"当地时间 4 月 14 日，辉瑞宣布终止开发口服胰高血糖素样肽-1受体激动剂 Danuglipron。安慰剂校正后，32 周时平均体重下降 8% 至 13%，26 周时平均体重下降 5% 至 9.5%。然而此次出现的潜在肝损伤病例，每日一次的Danuglipron 也终被辉瑞放弃。Danuglipron 并不是辉瑞在肥胖领域首次折戟的药物。在先后终止 Lotiglipron 和Danuglipron 开发后，目前辉瑞的肥胖药物管线仅剩一款口服 GIPR 拮抗剂PF-07976016，全球最高状态处于临床 II 期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415200413a459a994&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415200413a459a994&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","LU0456855351.SGD","LU0985481810.HKD","BK4007","SG9999013999.USD","IE00BLSP4239.USD","BK4581","LU0234572021.USD","LU1894683348.USD","BK4592","SG9999011175.SGD","IE00BBT3K403.USD","SGXZ57979304.SGD","LU0306806265.USD","BK4534","LU1894683264.USD","LU0170899867.USD","IE00B19Z3581.USD","BK4590","LU0225284248.USD","LU0321505439.SGD","SG9999002224.SGD","LU0321505868.SGD","LU1066051498.USD","LU1023059063.AUD","BK4533","SG9999001176.USD","IE00B19Z3B42.SGD","SG9999003800.SGD","LU0289739699.SGD","LU0868494617.USD","PFE","LU0058720904.USD","IE0002270589.USD","LU0306807586.USD","BK4588","BK4144","LU0225771236.USD","BK4568","IE000M9KFDE8.USD","SG9999001176.SGD","BK4550","BK4599","LU1066053197.SGD","SG9999002232.USD","LU0122379950.USD","LU1883839398.USD","GLP","LU1057294990.SGD","IE00BLSP4452.SGD"],"gpt_icon":1},{"id":"2527010965","title":"輝瑞4月14日成交額為13.66億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527010965","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527010965?lang=zh_tw&edition=fundamental","pubTime":"2025-04-15 10:09","pubTimestamp":1744682987,"startTime":"0","endTime":"0","summary":"美东时间2025年4月14日，辉瑞成交额为13.66亿美元，成交额较昨日增加14.34%，当日成交量为6190.09万股。辉瑞于2025年4月14日涨0.96%，报22.12美元，该股过去5个交易日跌2.25%，年初至今跌15.24%，过去60日跌15.11%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-14|13.66亿|14.34%|6190.09万|#|2025-04-11|11.95亿|-24.16%|5507.81万|#|2025-04-10|15.75亿|-24.50%|7296.07万|#|2025-04-09|20.87亿|30.20%|9595.44万|#|2025-04-08|16.03亿|-17.07%|7240.60万|辉瑞是全球最大的制药公司之一，年销售额接近500亿美元。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415100950a6bab065&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415100950a6bab065&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1894683348.USD","SG9999001176.SGD","IE000M9KFDE8.USD","LU0985481810.HKD","LU0306806265.USD","LU0321505439.SGD","LU1057294990.SGD","LU1066051498.USD","LU0225284248.USD","BK4599","LU0321505868.SGD","BK4568","LU1066053197.SGD","LU1894683264.USD","PFE","SG9999013999.USD","LU0170899867.USD","BK4581","IE00BBT3K403.USD","LU0122379950.USD","LU0234572021.USD","BK4550","BK4534","BK4592","SG9999002232.USD","LU0868494617.USD","LU1883839398.USD","BK4533","SG9999003800.SGD","LU0289739699.SGD","IE0002270589.USD","IE00BLSP4239.USD","LU0058720904.USD","BK4585","LU0306807586.USD","SG9999001176.USD","SGXZ57979304.SGD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","IE00BLSP4452.SGD","SG9999011175.SGD","LU1023059063.AUD","LU0225771236.USD","BK4007","BK4588","SG9999002224.SGD","LU0456855351.SGD"],"gpt_icon":1},{"id":"2527109468","title":"諾和諾德4月14日成交額為5.33億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527109468","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527109468?lang=zh_tw&edition=fundamental","pubTime":"2025-04-15 10:04","pubTimestamp":1744682657,"startTime":"0","endTime":"0","summary":"美东时间2025年4月14日，诺和诺德成交额为5.33亿美元，成交额较昨日减少27.17%，当日成交量为806.73万股。诺和诺德于2025年4月14日涨2.05%，报66.06美元，该股过去5个交易日涨3.8%，年初至今跌22.29%，过去60日跌19.53%。诺和诺德还有一个生物制药部门，专门从事血友病和其他疾病的蛋白质疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415100423a6baaf7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415100423a6baaf7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVO","BK4532","LU1093756325.SGD","BK4585","BK4588","IE00BZ1G4Q59.USD","BK4599","IE00BKVL7J92.USD","BK4007","LU0154236417.USD","LU1093756168.USD"],"gpt_icon":1},{"id":"2527436727","title":"輝瑞的GLP失敗了","url":"https://stock-news.laohu8.com/highlight/detail?id=2527436727","media":"生物药大时代","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527436727?lang=zh_tw&edition=fundamental","pubTime":"2025-04-15 09:44","pubTimestamp":1744681496,"startTime":"0","endTime":"0","summary":"4月14日，辉瑞宣布终止开发口服胰高血糖素样肽-1受体激动剂danuglipron，该药物此前正在研究用于慢性体重管理。在审查了所有信息，包括迄今为止为danuglipron生成的所有临床数据和监管机构的最新沟通后，辉瑞决定停止该分子的开发。市场对辉瑞制药撤回danuglipron的反应似乎有利于维京医疗、礼来和诺和诺德公司，因为慢性体重管理GLP-1受体激动剂领域的竞争可能会减少。因此，投资者对这些可能填补辉瑞制药退出这一药物类别留下空白的公司表现出更大兴趣。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415131247a4594490&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415131247a4594490&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4592","IE00BBT3K403.USD","LU0170899867.USD","LU0058720904.USD","BK4588","LU0868494617.USD","BK4590","LU0306806265.USD","BK4581","BK4568","LU1894683264.USD","IE00B19Z3B42.SGD","LU0122379950.USD","BK4599","LU0321505868.SGD","IE00B19Z3581.USD","LU0289739699.SGD","LU0225284248.USD","IE00BLSP4452.SGD","SG9999002224.SGD","BK4533","LU0306807586.USD","BK4585","BK4144","IE00BLSP4239.USD","LU1883839398.USD","LU1057294990.SGD","LU0234572021.USD","LU0985481810.HKD","LU1066053197.SGD","LU1023059063.AUD","SG9999003800.SGD","SG9999011175.SGD","IE000M9KFDE8.USD","IE0002270589.USD","SG9999013999.USD","BK4534","SG9999002232.USD","LU0321505439.SGD","BK4007","LU0225771236.USD","PFE","SG9999001176.USD","GLP","LU0456855351.SGD","BK4550","SG9999001176.SGD","SGXZ57979304.SGD","LU1894683348.USD","LU1066051498.USD"],"gpt_icon":1},{"id":"2527172422","title":"安進4月14日成交額為7.28億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527172422","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527172422?lang=zh_tw&edition=fundamental","pubTime":"2025-04-15 09:15","pubTimestamp":1744679747,"startTime":"0","endTime":"0","summary":"美东时间2025年4月14日，安进成交额为7.28亿美元，成交额较昨日减少26.10%，当日成交量为249.30万股。安进于2025年4月14日涨2.78%，报293.92美元，该股过去5个交易日涨1.46%，年初至今涨13.68%，过去60日涨9.97%。安进于 2006 年推出了首款癌症治疗药物 Vectibix，并销售骨强化药物 Prolia/Xgeva和 Evenity。同时，安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415091604a4591a97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415091604a4591a97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU1571399168.USD","LU0109394709.USD","LU0289739699.SGD","LU0122379950.USD","LU1983299246.USD","IE0002141913.USD","IE00B4R5TH58.HKD","BK4533","BK4588","LU0320765992.SGD","SG9999001440.SGD","AMGN","BK4581","IE0009355771.USD","IE00BJT1NW94.SGD","LU2468319806.SGD","LU2089984988.USD","IE00BFTCPJ56.SGD","BK4585","IE00BJJMRZ35.SGD","LU2242652126.USD","LU0889565916.HKD","LU0058720904.USD","LU1057294990.SGD","BK4599","LU0868494617.USD","LU2242646821.SGD","LU1061106388.HKD","LU1023059063.AUD","BK4566","BK4534","IE00B2B36J28.USD","LU2112291526.USD"],"gpt_icon":0},{"id":"2527652791","title":"金十數據整理：每日美股市場要聞速遞（4月14日，週一）","url":"https://stock-news.laohu8.com/highlight/detail?id=2527652791","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527652791?lang=zh_tw&edition=fundamental","pubTime":"2025-04-14 21:00","pubTimestamp":1744635658,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["03347","LU1917777945.USD","LU0528227936.USD","X","LU0323591593.USD","LU2247934214.USD","LU1064131342.USD","PFE","BK4077","IE00B7KXQ091.USD","LU1206712785.SGD","LU2077746001.SGD","BK4599","LLY","LU0795875169.SGD","LU0784385840.USD","LU0354030511.USD","IE00B19Z8W00.USD","CHA","IE00BJJMRX11.SGD","LU1496350502.SGD","AAPL","LU0314106906.USD","LU2237443549.SGD","LU1582987597.SGD","LU0314104364.USD","LU1861559042.SGD","LU1670710588.SGD","LU1668664300.SGD","LU2602419157.SGD","LU1564329115.USD","LU0109391861.USD","LU1989764664.SGD","LU0823421333.USD","BK4504","SONY","LU2065171402.SGD","LU1989772923.USD","INTC","LU2237438978.USD","MACW.SI","LU0820562030.AUD","LU1267930490.SGD","LU0079474960.USD","LU1316542783.SGD","FTC","IE00BKDWB100.SGD","BK4592","LU1935042215.USD","META"],"gpt_icon":1},{"id":"2527106152","title":"輝瑞終止每日服用減肥藥物研發後股價下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2527106152","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527106152?lang=zh_tw&edition=fundamental","pubTime":"2025-04-14 20:10","pubTimestamp":1744632600,"startTime":"0","endTime":"0","summary":"辉瑞表示将停止其每日服用减肥药物的研发后，其股价在盘前交易中下跌超过 1%。此前，在一项试验中，一名患者出现可能由该药物引起的肝损伤。\n　　辉瑞首席科学官克里斯・博肖夫博士在新闻稿中表示：“虽然我们对终止达努格列酮的研发感到失望，但我们仍致力于评估和推进有前景的项目，努力为患者带来创新的新药。”\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：郭明煜","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-04-14/doc-inetcuqq9269022.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0321505439.SGD","BK4534","IE0002270589.USD","IE00BLSP4452.SGD","LU1066053197.SGD","LU0225771236.USD","LU1057294990.SGD","LU0868494617.USD","LU0058720904.USD","LU0225284248.USD","BK4585","LU1066051498.USD","SG9999003800.SGD","BK4550","IE000M9KFDE8.USD","LU1883839398.USD","SG9999013999.USD","IE00BBT3K403.USD","IE00B19Z3581.USD","SG9999002232.USD","LU0985481810.HKD","LU0306807586.USD","BK4599","IE00BLSP4239.USD","LU0306806265.USD","LU0122379950.USD","BK4007","LU0289739699.SGD","BK4588","LU0456855351.SGD","LU1894683348.USD","BK4592","LU1894683264.USD","SG9999001176.SGD","BK4533","SGXZ57979304.SGD","IE00B19Z3B42.SGD","BK4568","LU1023059063.AUD","LU0170899867.USD","PFE","SG9999001176.USD","LU0234572021.USD","SG9999002224.SGD","LU0321505868.SGD","BK4581","SG9999011175.SGD"],"gpt_icon":0},{"id":"2527915162","title":"輝瑞(PFE.US)“減肥藥雄心”破碎：患者肝損傷導致Danuglipron開發終止","url":"https://stock-news.laohu8.com/highlight/detail?id=2527915162","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527915162?lang=zh_tw&edition=fundamental","pubTime":"2025-04-14 19:50","pubTimestamp":1744631431,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，辉瑞将停止开发备受关注的口服减肥药Danuglipron，因为一名参加临床试验的患者出现了潜在的药物性肝损伤。辉瑞在研发减肥药物方面已经落后于竞争对手。此前，辉瑞被迫停止开发每日服用两次的Danuglipron，原因是恶心和呕吐的高发率导致患者退出了一项约1400人参与的中期研究。辉瑞的决定可能会让一些投资者松一口气，他们一直怀疑Danuglipron能否与其他减肥药形成有效竞争。停止开发Danuglipron也可能促使辉瑞寻求收购交易。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1278327.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4534","BK4588","LU0122379950.USD","LU1066053197.SGD","LU1066051498.USD","IE00BLSP4452.SGD","BK4568","LU1894683264.USD","LU0985481810.HKD","SGXZ57979304.SGD","BK4581","IE00BBT3K403.USD","LU1057294990.SGD","LU0225284248.USD","SG9999001176.USD","IE0002270589.USD","LU1883839398.USD","LU0225771236.USD","LU0868494617.USD","SG9999013999.USD","SG9999002224.SGD","LU0170899867.USD","BK4585","LU0234572021.USD","BK4533","LU0321505868.SGD","BK4550","SG9999011175.SGD","LU0306807586.USD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","PFE","LU1023059063.AUD","LU0058720904.USD","BK4592","LU0321505439.SGD","SG9999001176.SGD","IE000M9KFDE8.USD","LU0306806265.USD","LU0289739699.SGD","BK4007","BK4599","LU1894683348.USD","SG9999003800.SGD","SG9999002232.USD","LU0456855351.SGD","IE00B19Z3581.USD"],"gpt_icon":1},{"id":"2527115822","title":"輝瑞(PFE.N)抹去盤前跌幅，現漲1.2%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2527115822","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527115822?lang=zh_tw&edition=fundamental","pubTime":"2025-04-14 18:58","pubTimestamp":1744628298,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK4568","BK4588","SG9999013999.USD","SG9999002224.SGD","LU0321505439.SGD","SG9999001176.USD","LU0306806265.USD","IE00BBT3K403.USD","BK4599","LU1066051498.USD","LU1066053197.SGD","PFE","SG9999001176.SGD","IE00BLSP4452.SGD","BK4534","IE00B19Z3581.USD","SG9999002232.USD","BK4007","LU0868494617.USD","LU0170899867.USD","LU0225284248.USD","LU0234572021.USD","IE0002270589.USD","LU0456855351.SGD","LU1883839398.USD","IE00B19Z3B42.SGD","BK4533","SG9999003800.SGD","LU1894683348.USD","LU0122379950.USD","LU0058720904.USD","LU1894683264.USD","SG9999011175.SGD","LU1057294990.SGD","IE000M9KFDE8.USD","IE00BLSP4239.USD","BK4550","LU0306807586.USD","LU0289739699.SGD","LU0985481810.HKD","BK4581","LU0321505868.SGD","BK4592","BK4585","LU1023059063.AUD","SGXZ57979304.SGD","LU0225771236.USD"],"gpt_icon":0},{"id":"2527130306","title":"因輝瑞放棄肥胖藥物，諾和諾德(NVO.N)盤前上漲4.7%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2527130306","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527130306?lang=zh_tw&edition=fundamental","pubTime":"2025-04-14 18:55","pubTimestamp":1744628112,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK4592","IE00BLSP4239.USD","SG9999013999.USD","LU0234572021.USD","SG9999011175.SGD","IE00B19Z3581.USD","BK4588","IE00BKVL7J92.USD","LU0456855351.SGD","LU0306806265.USD","BK4534","LU1894683264.USD","SG9999003800.SGD","SGXZ57979304.SGD","LU0321505439.SGD","BK4581","LU0225284248.USD","IE00B19Z3B42.SGD","BK4550","LU0985481810.HKD","PFE","SG9999001176.USD","IE00BBT3K403.USD","LU0225771236.USD","LU0122379950.USD","IE00BZ1G4Q59.USD","LU0170899867.USD","LU0058720904.USD","LU1066051498.USD","NVO","BK4599","BK4585","LU1023059063.AUD","SG9999001176.SGD","IE00BLSP4452.SGD","LU0289739699.SGD","LU1093756168.USD","SG9999002224.SGD","SG9999002232.USD","LU0154236417.USD","LU0306807586.USD","BK4568","LU0868494617.USD","LU1093756325.SGD","BK4533","LU1894683348.USD","LU0321505868.SGD","BK4007","LU1057294990.SGD","LU1066053197.SGD"],"gpt_icon":0},{"id":"2527137712","title":"輝瑞(PFE.N)盤前股價下跌3.2%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2527137712","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527137712?lang=zh_tw&edition=fundamental","pubTime":"2025-04-14 18:46","pubTimestamp":1744627602,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU0456855351.SGD","BK4599","BK4534","BK4581","BK4592","LU0234572021.USD","LU1057294990.SGD","BK4585","PFE","BK4533","IE00BLSP4239.USD","SG9999002232.USD","LU1883839398.USD","SG9999013999.USD","LU1066051498.USD","IE00B19Z3B42.SGD","IE00BBT3K403.USD","LU0306807586.USD","LU0058720904.USD","LU0225284248.USD","LU0321505868.SGD","SG9999011175.SGD","LU0225771236.USD","IE0002270589.USD","LU1894683264.USD","IE00BLSP4452.SGD","BK4568","BK4007","IE00B19Z3581.USD","LU1023059063.AUD","IE000M9KFDE8.USD","LU0306806265.USD","LU0122379950.USD","LU1066053197.SGD","SG9999003800.SGD","SG9999001176.SGD","LU0289739699.SGD","LU0868494617.USD","LU1894683348.USD","SG9999001176.USD","SGXZ57979304.SGD","LU0321505439.SGD","SG9999002224.SGD","LU0985481810.HKD","BK4588","LU0170899867.USD","BK4550"],"gpt_icon":0},{"id":"2527697850","title":"瑞士山德士公司在美國對安進公司提起反壟斷訴訟","url":"https://stock-news.laohu8.com/highlight/detail?id=2527697850","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527697850?lang=zh_tw&edition=fundamental","pubTime":"2025-04-14 13:08","pubTimestamp":1744607327,"startTime":"0","endTime":"0","summary":"瑞士山德士公司在美国对安进公司提起反垄断诉讼路透4月14日 - 瑞士仿制药生产商山德士SDZ.S周一表示，它已在美国提起反垄断诉讼，起诉安进AMGN.O巩固其大片药物Enbrel(etanercept) 的市场支配地位。 (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nL4T3QS0CX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0122379950.USD","AMGN","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","BK4585","LU2242646821.SGD","IE0009355771.USD","LU0889565916.HKD","LU2089984988.USD","LU0289739699.SGD","BK4533","IE00BJT1NW94.SGD","LU1061106388.HKD","LU1983299246.USD","BK4139","LU0109394709.USD","LU1571399168.USD","IE00B2B36J28.USD","LU1023059063.AUD","LU1057294990.SGD","SG9999001440.SGD","BK4534","BK4566","LU2242652126.USD","BK4599","BK4581","LU0058720904.USD","LU2468319806.SGD","LU0868494617.USD","LU2112291526.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2526672932","title":"禮來(LLY.US)公佈減肥藥Zepbound三年臨牀數據 持續用藥可維持95%減重效果","url":"https://stock-news.laohu8.com/highlight/detail?id=2526672932","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526672932?lang=zh_tw&edition=fundamental","pubTime":"2025-04-12 14:20","pubTimestamp":1744438811,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，礼来公司的减肥注射药Zepbound长期用药患者研究显示，定期使用该药的患者三年内体重反弹幅度通常不超过减重量的5%，且多数人反弹比例低于5%。礼来去年公布了这项为期三年的试验的初步数据，显示接受最高15毫克剂量治疗的患者平均减重23%。研究结果表明，按医嘱持续使用Zepbound等药物可实现长期疗效。需持续用药然而，坚持用药是关键。此前研究显示，完全停用Zepbound的患者会出现显著体重反弹。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1277752.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"礼来(LLY.US)公布减肥药Zepbound三年临床数据 持续用药可维持95%减重效果","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["GB00BDT5M118.USD","LU0106261372.USD","IE0004445239.USD","LU2211815571.USD","LU1551013425.SGD","SG9999001176.USD","LU0122379950.USD","IE00B4R5TH58.HKD","LU0354030511.USD","LU1868837136.USD","SG9999015978.USD","LU0672654240.SGD","LU1720051017.SGD","LU0640476718.USD","LU1267930730.SGD","LU0471298694.HKD","LU0198837287.USD","IE00BJJMRZ35.SGD","LU1291159041.SGD","LU0058720904.USD","LU0109391861.USD","BK4599","LU2357305700.SGD","BK4516","LU1974910355.USD","SG9999015945.SGD","LU0471298777.SGD","LU2063271972.USD","LU0354030438.USD","LU2552382058.USD","LU1868836591.USD","LU2552382132.HKD","LU1093756168.USD","LU2750360997.AUD","BK4534","LU1035775433.USD","LU2461242641.AUD","LU2237443895.HKD","LU1366192091.USD","LU0820561818.USD","LU1988902786.USD","LU1232071149.USD","LLY","BK4581","BK4007","LU0289739699.SGD","LU2471134952.CNY","LU1983299246.USD","LU2360106947.USD","LU0708995401.HKD"],"gpt_icon":1},{"id":"2526861922","title":"Altimmune, Inc.盤中異動 下午盤股價大漲5.05%報4.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526861922","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526861922?lang=zh_tw&edition=fundamental","pubTime":"2025-04-12 01:53","pubTimestamp":1744394027,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日01时53分，Altimmune, Inc.股票出现异动，股价大幅拉升5.05%。截至发稿，该股报4.37美元/股，成交量76.3477万股，换手率0.99%，振幅5.89%。Altimmune, Inc.股票所在的生物技术行业中，整体涨幅为1.87%。其相关个股中，Protagenic Therapeutics Inc C/Wts 26/04/2026 、Portage Biotech Inc.、Theratechnologies Inc.涨幅较大，Hepion Pharmaceuticals, Inc.、Portage Biotech Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为2122.14%、1676.89%、400.18%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、Portage Biotech Inc.、Theratechnologies Inc.，振幅分别为193.75%、156.27%、77.44%。Altimmune, Inc.公司简介：Altimmune Inc 从事开发治疗肥胖症和肝病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412015347a6b8083f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412015347a6b8083f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1878469433.USD","ALT","BK4599","BK4139"],"gpt_icon":0},{"id":"2526198936","title":"碩迪生物盤中異動 急速拉昇5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2526198936","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526198936?lang=zh_tw&edition=fundamental","pubTime":"2025-04-12 01:40","pubTimestamp":1744393213,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日01时40分，硕迪生物股票出现波动，股价快速上涨5.12%。截至发稿，该股报15.82美元/股，成交量27.2913万股，换手率0.48%，振幅5.06%。机构评级方面，在所有13家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。硕迪生物股票所在的生物技术行业中，整体涨幅为1.46%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412014013a45667ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412014013a45667ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","GPCR","BK4599"],"gpt_icon":0},{"id":"2526667750","title":"諾和諾德盤中異動 股價大漲4.21%報63.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526667750","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526667750?lang=zh_tw&edition=fundamental","pubTime":"2025-04-11 21:32","pubTimestamp":1744378350,"startTime":"0","endTime":"0","summary":"北京时间2025年04月11日21时32分，诺和诺德股票出现波动，股价快速上涨4.21%。截至发稿，该股报63.79美元/股，成交量75.0618万股，换手率0.02%，振幅0.74%。最近的财报数据显示，该股实现营业收入421.15亿美元，净利润146.46亿美元，每股收益3.29美元，毛利353.13亿美元，市盈率20.24倍。诺和诺德股票所在的制药行业中，整体跌幅为0.11%。健友股份在公告中表示，新批准产品近期将安排在美国上市销售，有望对公司经营业绩产生积极影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411213230a4563b67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411213230a4563b67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756168.USD","NVO","IE00BZ1G4Q59.USD","LU0154236417.USD","BK4585","BK4588","BK4599","BK4007","LU1093756325.SGD","BK4532","IE00BKVL7J92.USD"],"gpt_icon":1},{"id":"2526475571","title":"輝瑞4月10日成交額為15.75億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526475571","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526475571?lang=zh_tw&edition=fundamental","pubTime":"2025-04-11 10:14","pubTimestamp":1744337668,"startTime":"0","endTime":"0","summary":"美东时间2025年4月10日，辉瑞成交额为15.75亿美元，成交额较昨日减少24.50%，当日成交量为7296.07万股。辉瑞于2025年4月10日跌4.0%，报21.59美元，该股过去5个交易日跌11.12%，年初至今跌17.27%，过去60日跌16.9%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-10|15.75亿|-24.50%|7296.07万|#|2025-04-09|20.87亿|30.20%|9595.44万|#|2025-04-08|16.03亿|-17.07%|7240.60万|#|2025-04-07|19.33亿|3.74%|8610.61万|#|2025-04-04|18.63亿|41.94%|8000.26万|辉瑞是全球最大的制药公司之一，年销售额接近500亿美元。辉瑞在全球销售这些产品，国际销售额占其总销售额的近50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411101435a455a457&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411101435a455a457&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4534","BK4588","LU0122379950.USD","LU1066053197.SGD","LU1066051498.USD","IE00BLSP4452.SGD","BK4568","LU1894683264.USD","LU0985481810.HKD","SGXZ57979304.SGD","BK4581","IE00BBT3K403.USD","LU1057294990.SGD","LU0225284248.USD","SG9999001176.USD","IE0002270589.USD","LU1883839398.USD","LU0225771236.USD","LU0868494617.USD","SG9999013999.USD","SG9999002224.SGD","LU0170899867.USD","BK4585","LU0234572021.USD","BK4533","LU0321505868.SGD","BK4550","SG9999011175.SGD","LU0306807586.USD","IE00B19Z3B42.SGD","IE00BLSP4239.USD","PFE","LU1023059063.AUD","LU0058720904.USD","BK4592","LU0321505439.SGD","SG9999001176.SGD","IE000M9KFDE8.USD","LU0306806265.USD","LU0289739699.SGD","BK4007","BK4599","LU1894683348.USD","SG9999003800.SGD","SG9999002232.USD","LU0456855351.SGD","IE00B19Z3581.USD"],"gpt_icon":1},{"id":"2526574847","title":"諾和諾德4月10日成交額為6.10億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526574847","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526574847?lang=zh_tw&edition=fundamental","pubTime":"2025-04-11 10:09","pubTimestamp":1744337342,"startTime":"0","endTime":"0","summary":"美东时间2025年4月10日，诺和诺德成交额为6.10亿美元，成交额较昨日减少26.07%，当日成交量为998.40万股。诺和诺德于2025年4月10日跌5.96%，报61.21美元，该股过去5个交易日跌8.78%，年初至今跌27.99%，过去60日跌23.7%。诺和诺德还有一个生物制药部门，专门从事血友病和其他疾病的蛋白质疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411100912a455a34a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411100912a455a34a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ1G4Q59.USD","LU1093756325.SGD","BK4585","LU1093756168.USD","BK4007","BK4588","BK4599","NVO","BK4532","IE00BKVL7J92.USD","LU0154236417.USD"],"gpt_icon":1},{"id":"2526791895","title":"禮來4月10日成交額為29.99億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526791895","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526791895?lang=zh_tw&edition=fundamental","pubTime":"2025-04-11 09:50","pubTimestamp":1744336213,"startTime":"0","endTime":"0","summary":"美东时间2025年4月10日，礼来成交额为29.99亿美元，成交额较昨日减少37.21%，当日成交量为418.27万股。礼来于2025年4月10日跌4.35%，报720.91美元，该股过去5个交易日跌8.64%，年初至今跌6.46%，过去60日跌3.06%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-10|29.99亿|-37.21%|418.27万|#|2025-04-09|47.77亿|57.32%|661.90万|#|2025-04-08|30.36亿|-32.23%|411.52万|#|2025-04-07|44.80亿|13.19%|627.44万|#|2025-04-04|39.58亿|85.61%|529.94万|礼来制药公司是一家专注于神经科学、心脏代谢、癌症和免疫学的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411095021a6b74317&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411095021a6b74317&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1804176565.USD","LU2361044949.HKD","LU2089984988.USD","LU1366192091.USD","BK4007","LU2750360997.AUD","LU1551013342.USD","LU2461242641.AUD","LLY","LU2750360641.GBP","LU0640476718.USD","SGXZ51526630.SGD","IE00BFTCPJ56.SGD","BK4581","LU0203202063.USD","BK4588","LU2237438978.USD","LU2602419157.SGD","LU1712237335.SGD","LU2361045086.USD","LU2063271972.USD","BK4516","LU2491050154.USD","LU1868836591.USD","BK4599","LU1868837136.USD","IE0009355771.USD","LU2360106947.USD","LU0096364046.USD","SG9999017495.SGD","LU1548497426.USD","SGXZ81514606.USD","LU0456855351.SGD","SG9999013999.USD","LU0256863811.USD","LU0094547139.USD","LU2112291526.USD","LU0385154629.USD","LU1267930730.SGD","LU0079474960.USD","IE00B2B36J28.USD","SGXZ57979304.SGD","IE00BJT1NW94.SGD","LU2552382215.SGD","IE00BJJMRZ35.SGD","LU1868837300.USD","LU2106854487.HKD","LU1057294990.SGD","LU0354030511.USD","LU0471298694.HKD"],"gpt_icon":1},{"id":"2526157829","title":"安進4月10日成交額為13.08億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526157829","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526157829?lang=zh_tw&edition=fundamental","pubTime":"2025-04-11 09:16","pubTimestamp":1744334160,"startTime":"0","endTime":"0","summary":"美东时间2025年4月10日，安进成交额为13.08亿美元，成交额较昨日减少24.30%，当日成交量为467.91万股。安进于2025年4月10日跌3.33%，报281.41美元，该股过去5个交易日跌9.18%，年初至今涨8.84%，过去60日涨6.21%。安进于 2006 年推出了首款癌症治疗药物 Vectibix，并销售骨强化药物 Prolia/Xgeva和 Evenity。同时，安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411091621a6b73836&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250411091621a6b73836&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0009355771.USD","LU0889565916.HKD","LU1983299246.USD","LU0058720904.USD","BK4588","LU0868494617.USD","LU2242652126.USD","LU1061106388.HKD","BK4581","LU0122379950.USD","BK4599","LU0289739699.SGD","LU2242646821.SGD","BK4533","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU2112291526.USD","IE00BJT1NW94.SGD","LU2089984988.USD","LU1571399168.USD","BK4585","AMGN","LU1057294990.SGD","IE00B4R5TH58.HKD","LU1023059063.AUD","BK4566","BK4534","IE0002141913.USD","LU2468319806.SGD","LU0320765992.SGD","BK4139","SG9999001440.SGD"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":112,"code":"91000000","status":"200"}]}}